De Novo Immunosuppression With Sirolimus and Tacrolimus in Heart Transplant Recipients Compared With Cyclosporine and Mycophenolate Mofetil: A One-Year Follow-Up Analysis
- 17 June 2005
- journal article
- clinical trial
- Published by Elsevier in Transplantation Proceedings
- Vol. 37 (5) , 2231-2239
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathyEuropean Heart Journal, 2003
- The registry of the international society for heart and lung transplantation: twentieth official adult heart transplant report—2003The Journal of Heart and Lung Transplantation, 2003
- Impact of cardiac transplantation on kidney function: a single- center experienceTransplantation Proceedings, 2003
- Sirolimus therapy in cardiac transplantationTransplantation Proceedings, 2003
- Hypertension in heart transplant recipients: more than just cyclosporine**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.JACC, 2003
- Cardiovascular Toxicities of Immunosuppressive AgentsAmerican Journal of Transplantation, 2002
- INCIDENCE, PROGRESSION AND FUNCTIONAL SIGNIFICANCE OF CARDIAC ALLOGRAFT VASCULOPATHY AFTER HEART TRANSPLANTATION1Transplantation, 2000
- Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the futureAmerican Journal of Kidney Diseases, 2000
- Mechanisms of hypertension in cardiac transplantation and the role of cyclosporineCurrent Opinion in Cardiology, 1997
- Time Course of the Decline in Renal Function in Cyclosporine-Treated Heart Transplant RecipientsAmerican Journal of Nephrology, 1994